Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Business Development & Partnering Team are delighted to announce that the AIMday in Advanced Therapies & Regenerative Medicine is now open for registration by academics.

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? 

If you answer YES to any of the above, now is the time to register for the AIMday in Advanced Therapies & Regenerative Medicine, taking place on Wednesday 3 April at the Blavatnik School of Government. A range of companies including LIft Biosciences, Alcyomics, Oxford MEStar, Novo Nordisk, DJS Antibodies, The Electrospinning Company and Bio-Techne are registered to attend, and it will be a fantastic opportunity for researchers looking to network with industry and discuss relevant questions. To see the questions posed by these companies, please visit aimday.se/atrm-2019/questions-listing.

This years AIMday follows on from previous successful AIMdays in Ageing (2016), Microscopy (2017) and Biomedical Imaging (2018).

FREE registration for academics is now open and closes on 15 March. 

Please note, advance registration is essential

To register and find out more, please visit aimday.se/ATRM-2019

What are AIMdays?

  • AIMdays provide a platform for companies to host roundtable discussions with a group of self-selecting academics
  • Industry sets the agenda and topics for discussion
  • Academics from across multiple disciplines sign up to participate in the discussions

How does it work?

Step 1: Companies submit a question/s around the theme of the day

Step 2: Oxford’s researchers sign up to answer one or more of the questions

Step 3: One question, one hour for discussion, one group of experts

 

For additional information please contact amira.burshan@medsci.ox.ac.uk

Find out more about the work of the Business Development & Partnering Team

Similar stories

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.